Erste Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-14,470
| Closed | -$4.58M | – | 908 |
|
|
2023
Q4 | $4.58M | Buy |
14,470
+5,000
| +53% | +$1.58M | 0.07% | 233 |
|
|
2023
Q3 | $1.61M | Buy |
9,470
+2,400
| +34% | +$409K | 0.03% | 294 |
|
|
2023
Q2 | $1.53M | Hold |
7,070
| – | – | 0.03% | 314 |
|
|
2023
Q1 | $1.27M | Hold |
7,070
| – | – | 0.02% | 326 |
|
|
2022
Q4 | $1.37M | Hold |
7,070
| – | – | 0.03% | 313 |
|
|
2022
Q3 | $1.59M | Hold |
7,070
| – | – | 0.04% | 306 |
|
|
2022
Q2 | $884K | Hold |
7,070
| – | – | 0.02% | 371 |
|
|
2022
Q1 | $870K | Hold |
7,070
| – | – | 0.02% | 373 |
|
|
2021
Q4 | $932K | Hold |
7,070
| – | – | 0.02% | 362 |
|
|
2021
Q3 | $840K | Hold |
7,070
| – | – | 0.02% | 351 |
|
|
2021
Q2 | $787K | Buy |
+7,070
| New | +$787K | 0.02% | 368 |
|